Catalyst Wire Dossier Catalyst Wire Dossier

E6 TCR-T cells

E6 TCR-T cells · National Cancer Institute (NCI)
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for E6 TCR-T cells, covering 2019-10-08 to 2019-10-08. Get the full timeline:

Most recent: Clinical Trial Update: Immunotherapy With E6 T Cell Receptor (TCR) T Cells for Vulvar High-Grade Squamous Intraepithelial Lesions [Phase 1]

See pricing